Melissa Tosca
Equibles does not estimate personal net worth.
Get an email with a short summary when Kiora Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get KPRX alertsAbout Melissa Tosca
Melissa Tosca is recorded as CFO at Kiora Pharmaceuticals Inc (KPRX). The newest filing on record that lists Melissa Tosca as CFO at Kiora Pharmaceuticals Inc (KPRX) is dated April 30, 2026. Kiora Pharmaceuticals Inc reported in an 8-K filed July 1, 2024 that Melissa Tosca was appointed Chief Financial Officer, effective July 1, 2024. Kiora Pharmaceuticals Inc reported in an 8-K filed September 16, 2022 that Melissa Tosca was appointed Executive Vice President of Finance, effective September 13, 2022. The proxy statement of Kiora Pharmaceuticals Inc reports total compensation of $516,733 for Melissa Tosca in fiscal 2025, including a base salary of $344,777. Disclosed compensation is on record for 5 fiscal years. Kiora Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Kiora Pharmaceuticals Inc includes Brian M. Strem (CEO and Board Member), Brian M. Strem, Ph.D. (CEO, CFO and Board Member), Praveen Tyle (Chairman and Board Member) and 7 others.
“On the Effective Date, the Company appointed Melissa Tosca, CPA as the Chief Financial Officer of the Company.”
“On September 13, 2022 (the "Effective Date"), Kiora Pharmaceuticals Inc. (the "Company") appointed Melissa Tosca as Executive Vice President of Finance of the Company, effective as of the Effective Date.”
Affiliation history
-
Kiora Pharmaceuticals Inc (KPRX)
Proxy statement
CurrentStart not stated–present
Last confirmed March 25, 2024
-
Current
Start not stated–present
Last confirmed April 30, 2026
Company network
Leadership on record at Kiora Pharmaceuticals Inc
- Brian M. Strem CEO, Board Member
- Brian M. Strem, Ph.D. CEO, CFO, Board Member
- Praveen Tyle Chairman, Board Member
- Praveen Tyle, Ph.D. Chairman, Board Member
- Stephen From Chairman
- Michael Meluzio, CPA CFO
- Susan L. Drexler CFO, Chief Accounting Officer
- Aron Shapiro Board Member
- Carmine Stengone Board Member
- David Hollander Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Kiora Pharmaceuticals Inc (KPRX) | Chief Financial Officer7 | $344,777 | $516,733 |
| 2024 | Kiora Pharmaceuticals Inc (KPRX) | Chief Financial Officer7 | $323,627 | $534,187 |
| 2023 | Kiora Pharmaceuticals Inc (KPRX) | Chief Financial Officer7 | $304,479 | $390,345 |
| 2022 | Kiora Pharmaceuticals Inc (KPRX) | Executive Vice President of Finance6 | $85,385 | $132,535 |
| 2021 | Kiora Pharmaceuticals Inc (KPRX) | Executive Vice President of Finance6 | — | — |